Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Retroviral vectors, including gammaretroviral and lentiviral vectors, offer permanent gene transfer into host cells for treating genetic disorders.
• Conventional gammaretroviral vectors have shown clinical success but carry risks of leukemia due to insertional mutagenesis.
• Lentiviral vectors can transduce non-dividing cells and have demonstrated efficacy in clinical trials for neurological conditions.

Purpose of the Study:

• To evaluate the safety and efficacy of lentiviral vectors in gene therapy compared to gammaretroviral vectors.
• To analyze vector integration sites and assess the risk of insertional mutagenesis associated with different retroviral vectors.
• To explore the potential of lentiviral vectors for treating a broader range of diseases.

Main Methods:

• Review of clinical trial data and vector integration site analyses for gammaretroviral and lentiviral vectors.
• Comparison of the integration profiles of lentiviruses and gammaretroviruses in host cell genomes.
• Assessment of adverse events reported in gene therapy clinical trials utilizing these vectors.

Main Results:

• Gammaretroviral vectors have led to successful gene expression and symptom improvement but also to serious side effects like leukemia from insertional mutagenesis.
• Lentiviral vectors demonstrate a lower likelihood of integrating near oncogene promoters compared to gammaretroviral vectors.
• No adverse events related to insertional mutagenesis have been reported in clinical trials using lentiviral vectors.

Conclusions:

• Lentiviral vectors represent a safer alternative to gammaretroviral vectors due to a reduced risk of insertional mutagenesis.
• The ability to transduce non-dividing cells and improved safety profile position lentiviral vectors for wider application in gene therapy.
• Further research and clinical application of lentiviral vectors hold significant potential for treating various inherited and acquired diseases, including cancer immunotherapy.